Status:

COMPLETED

Protecting Our Community: COVID-19 Testing

Lead Sponsor:

Montana State University

Collaborating Sponsors:

National Institute of General Medical Sciences (NIGMS)

University of Washington

Conditions:

SARS-CoV-2

Covid19

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The COVID-19 pandemic has disproportionately affected American Indian (AI) and Latino communities, and these groups also have increased risk of poor prognosis due to high rates of chronic disease such...

Detailed Description

This clinical trial utilizes community-based participatory research partnerships to test the hypothesis that home-based testing for COVID-19 will be feasible, impactful, and better accepted using acti...

Eligibility Criteria

Inclusion

  • 18 years old or older
  • Member of study community
  • No current significant symptoms consistent with COVID-19

Exclusion

  • \< 18 years old
  • Not a member of the study community
  • Current significant symptoms consistent with COVID-19

Key Trial Info

Start Date :

April 26 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 9 2022

Estimated Enrollment :

273 Patients enrolled

Trial Details

Trial ID

NCT04866303

Start Date

April 26 2021

End Date

March 9 2022

Last Update

December 7 2023

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Salish Kootenai College

Pablo, Montana, United States, 59855

2

Fred Hutchinson Cancer Research Center

Seattle, Washington, United States, 98109